China's Food and Drug Administration announced Tuesday that clinical data from four Taiwanese hospitals can be used when applying for drug permits in China, a "breakthrough" that industry leaders said will give Taiwan a leg up in developing into an Asia-Pacific hub for pharmaceutical research and trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
- Society
Amendments mean prosecutors must approve police urine sample demand
10/17/2025 09:00 PM - Society
Union angered at EVA Air's reluctance to address flight attendant's death
10/17/2025 07:54 PM - Society
Roadside barrier lake in Taroko prompts evacuations in Hualien
10/17/2025 06:54 PM - Politics
Special budget passed after cuts to MND's controversial water plan
10/17/2025 06:10 PM